Sagefield Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Sagefield Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-110,199	Closed	-$2.36M	–	118
2026 Q1	$2.36M	Buy	+110,199	New	+$1.55M	0.17%	93

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Sagefield Capital's DAWN Position: Q2 2026 in Review

Sagefield Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 110,199 shares — an estimated $2.36M sold.

Sagefield Capital first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $2.36M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Sagefield Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sagefield Capital sold 110,199 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.36M.
Sagefield Capital first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Sagefield Capital's Day One Biopharmaceuticals position peaked at $2.36M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Sagefield Capital's 13F filing for Q2 2026, filed 14 Aug 2026.